Adaptive Biotechnologies Corp (ADPT) stock is lower by -74.48% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ADPT stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 5. ADPT's rank also includes a long-term technical score of 6. The fundamental score for ADPT is 89. In addition to the average rating from Wall Street analysts, ADPT stock has a mean target price of $36.33. This means analysts expect the stock to gain 234.25% over the next 12 months. ADPT has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ADPT!